Global Submucosal Injections Market Research Report 2023

Publication ID:

PB504233267

Publication Date:

April 17, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The submucosal injections are required principally during the endoscopic mucosal resection techniques.They are an indispensable part of endoscopic submucosal dissection.听The most common submucosal injections were glucose water, hydroxypropyl methyl cellulose, normal saline, hyaluronic acid, hydroxyethyl starch and Orise gel.
Highlights
The global Submucosal Injections market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In recent years, there has been an increasing demand for endoscopic surgery, especially in developed economies.There has also been an increase in the number of patients seeking treatment for early gastric cancer or cancer in premature infants, which has contributed to the growth and demand for submucosal injections.All these factors will push the size of the submucosal injection market to expand
Report Scope
This report aims to provide a comprehensive presentation of the global market for Submucosal Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Injections.
The Submucosal Injections market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Submucosal Injections market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Submucosal Injections companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
COSMO PHARMACEUTICALS
Boston Scientific
Laborie锛圙I Supply)
The Standard Co., Ltd.
EndoClot Plus, Inc.
Micro-Tech Endoscopy
Seikagaku
Segment by Type
5 mL Syringe
10 mL Syringe
Segment by Application
Endoscopic Mucosal Resection (EMR)
Endoscopic Submucosal Dissection (ESD)
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Submucosal Injections companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Submucosal Injections Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 5 mL Syringe
1.2.3 10 mL Syringe
1.3 Market by Application
1.3.1 Global Submucosal Injections Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Endoscopic Mucosal Resection (EMR)
1.3.3 Endoscopic Submucosal Dissection (ESD)
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Submucosal Injections Market Perspective (2018-2029)
2.2 Submucosal Injections Growth Trends by Region
2.2.1 Global Submucosal Injections Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Submucosal Injections Historic Market Size by Region (2018-2023)
2.2.3 Submucosal Injections Forecasted Market Size by Region (2024-2029)
2.3 Submucosal Injections Market Dynamics
2.3.1 Submucosal Injections Industry Trends
2.3.2 Submucosal Injections Market Drivers
2.3.3 Submucosal Injections Market Challenges
2.3.4 Submucosal Injections Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Submucosal Injections Players by Revenue
3.1.1 Global Top Submucosal Injections Players by Revenue (2018-2023)
3.1.2 Global Submucosal Injections Revenue Market Share by Players (2018-2023)
3.2 Global Submucosal Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Submucosal Injections Revenue
3.4 Global Submucosal Injections Market Concentration Ratio
3.4.1 Global Submucosal Injections Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Submucosal Injections Revenue in 2022
3.5 Submucosal Injections Key Players Head office and Area Served
3.6 Key Players Submucosal Injections Product Solution and Service
3.7 Date of Enter into Submucosal Injections Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Submucosal Injections Breakdown Data by Type
4.1 Global Submucosal Injections Historic Market Size by Type (2018-2023)
4.2 Global Submucosal Injections Forecasted Market Size by Type (2024-2029)
5 Submucosal Injections Breakdown Data by Application
5.1 Global Submucosal Injections Historic Market Size by Application (2018-2023)
5.2 Global Submucosal Injections Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Submucosal Injections Market Size (2018-2029)
6.2 North America Submucosal Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Submucosal Injections Market Size by Country (2018-2023)
6.4 North America Submucosal Injections Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Submucosal Injections Market Size (2018-2029)
7.2 Europe Submucosal Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Submucosal Injections Market Size by Country (2018-2023)
7.4 Europe Submucosal Injections Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Submucosal Injections Market Size (2018-2029)
8.2 Asia-Pacific Submucosal Injections Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Submucosal Injections Market Size by Region (2018-2023)
8.4 Asia-Pacific Submucosal Injections Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Submucosal Injections Market Size (2018-2029)
9.2 Latin America Submucosal Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Submucosal Injections Market Size by Country (2018-2023)
9.4 Latin America Submucosal Injections Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Submucosal Injections Market Size (2018-2029)
10.2 Middle East & Africa Submucosal Injections Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Submucosal Injections Market Size by Country (2018-2023)
10.4 Middle East & Africa Submucosal Injections Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 COSMO PHARMACEUTICALS
11.1.1 COSMO PHARMACEUTICALS Company Detail
11.1.2 COSMO PHARMACEUTICALS Business Overview
11.1.3 COSMO PHARMACEUTICALS Submucosal Injections Introduction
11.1.4 COSMO PHARMACEUTICALS Revenue in Submucosal Injections Business (2018-2023)
11.1.5 COSMO PHARMACEUTICALS Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Submucosal Injections Introduction
11.2.4 Boston Scientific Revenue in Submucosal Injections Business (2018-2023)
11.2.5 Boston Scientific Recent Development
11.3 Laborie锛圙I Supply)
11.3.1 Laborie锛圙I Supply) Company Detail
11.3.2 Laborie锛圙I Supply) Business Overview
11.3.3 Laborie锛圙I Supply) Submucosal Injections Introduction
11.3.4 Laborie锛圙I Supply) Revenue in Submucosal Injections Business (2018-2023)
11.3.5 Laborie锛圙I Supply) Recent Development
11.4 The Standard Co., Ltd.
11.4.1 The Standard Co., Ltd. Company Detail
11.4.2 The Standard Co., Ltd. Business Overview
11.4.3 The Standard Co., Ltd. Submucosal Injections Introduction
11.4.4 The Standard Co., Ltd. Revenue in Submucosal Injections Business (2018-2023)
11.4.5 The Standard Co., Ltd. Recent Development
11.5 EndoClot Plus, Inc.
11.5.1 EndoClot Plus, Inc. Company Detail
11.5.2 EndoClot Plus, Inc. Business Overview
11.5.3 EndoClot Plus, Inc. Submucosal Injections Introduction
11.5.4 EndoClot Plus, Inc. Revenue in Submucosal Injections Business (2018-2023)
11.5.5 EndoClot Plus, Inc. Recent Development
11.6 Micro-Tech Endoscopy
11.6.1 Micro-Tech Endoscopy Company Detail
11.6.2 Micro-Tech Endoscopy Business Overview
11.6.3 Micro-Tech Endoscopy Submucosal Injections Introduction
11.6.4 Micro-Tech Endoscopy Revenue in Submucosal Injections Business (2018-2023)
11.6.5 Micro-Tech Endoscopy Recent Development
11.7 Seikagaku
11.7.1 Seikagaku Company Detail
11.7.2 Seikagaku Business Overview
11.7.3 Seikagaku Submucosal Injections Introduction
11.7.4 Seikagaku Revenue in Submucosal Injections Business (2018-2023)
11.7.5 Seikagaku Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

COSMO PHARMACEUTICALS
Boston Scientific
Laborie锛圙I Supply)
The Standard Co., Ltd.
EndoClot Plus, Inc.
Micro-Tech Endoscopy
Seikagaku

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂